ANXA6 抗体 (AA 5-23)
Quick Overview for ANXA6 抗体 (AA 5-23) (ABIN956781)
抗原
See all ANXA6 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 5-23
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- 
                        Synthetic peptide corresponding to aa 5 -23 of human Annexin VI.
 Type of Immunogen: Synthetic peptide
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: IHC (1:50), WB
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- 10 mM PBS, pH 7.4, BSA, sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
 
- 
                                            
- 
    - ANXA6 (Annexin A6 (ANXA6))
- 
                                            别名
- ANXA6/Annexin A6/Annexin VI
- 
                                            背景
- 
                        Name/Gene ID: ANXA6
 Synonyms: ANXA6, 67 kDa calelectrin, Annexin VI (p68), Annexin A6, Annexin VI, ANX6, Calcium-binding protein p68, Calelectrin, CBP68, Chromobindin-20, Calphobindin-II, Lipocortin VI, p70, Protein III, Annexin-6, Calphobindin II, CPB-II, p68
- 
                                            基因ID
- 309
 抗原
- 
                    
 
                                     
                                     
                                    